Stock listing
BOATS:CODX Co-Diagnostics, Inc. Stock
US listing (BOATS) of Co-Diagnostics, Inc. · home listing NASDAQ:CODX
Follow Co-Diagnostics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CODX
$0.13 USD -0.04 (-21.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CODX
- Day range
- $0.128 – $0.142 USDNov 20, 2026
- Volume
- 1.14M sharesNov 20, 2026
- Market cap
- $1.36M USDAt the close on Nov 20, 2026 · price × 10.51M shares outstanding
- 52-week range
- $0.128 – $13.54 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $730,291 USDMedian day 313,547 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CODX · Home | $0.13 USD | -0.035 (-21.3%) | 1,143,708 | $0.14 | $0.142 | $0.128 | $0.165 | Close on Nov 20, 2026 |
| LSE:0A50 | $0.13 USD | -0.039 (-23.3%) | 107,164 | $0.138 | $0.164 | $0.125 | $0.169 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CODX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.13 | -0.035 | -21.3% | $0.14 | $0.142 | $0.128 | 1,143,708 | |
| $0.165 | -0.033 | -16.7% | $0.19 | $0.19 | $0.162 | 1,106,485 | |
| $0.198 | +0.002 | +0.9% | $0.196 | $0.225 | $0.184 | 1,951,116 | |
| $0.196 | -0.029 | -12.9% | $0.205 | $0.209 | $0.172 | 992,914 | |
| $0.225 | -0.034 | -13.0% | $0.25 | $0.25 | $0.224 | 591,761 | |
| $0.259 | -0.011 | -4.1% | $0.269 | $0.269 | $0.245 | 591,938 | |
| $0.27 | -0.008 | -2.9% | $0.245 | $0.27 | $0.245 | 1,218,342 | |
| $0.278 | -0.011 | -3.8% | $0.279 | $0.295 | $0.25 | 3,888,316 | |
| $0.289 | -0.03 | -9.5% | $0.31 | $0.335 | $0.264 | 74,930,648 | |
| $0.319 | +0.062 | +24.2% | $0.273 | $0.345 | $0.262 | 24,151,910 | |
| $0.257 | -0.01 | -3.9% | $0.29 | $0.29 | $0.245 | 528,878 | |
| $0.267 | -0.094 | -26.1% | $0.376 | $0.39 | $0.265 | 1,035,473 | |
| $0.361 | -0.019 | -4.9% | $0.38 | $0.391 | $0.355 | 446,394 | |
| $0.38 | +0.027 | +7.6% | $0.39 | $0.39 | $0.367 | 354,002 | |
| $0.353 | -0.013 | -3.7% | $0.392 | $0.418 | $0.35 | 590,831 | |
| $0.367 | -0.028 | -7.2% | $0.40 | $0.404 | $0.365 | 236,047 | |
| $0.395 | -0.046 | -10.5% | $0.449 | $0.45 | $0.393 | 553,902 | |
| $0.441 | -0.028 | -5.9% | $0.496 | $0.496 | $0.435 | 335,175 | |
| $0.469 | -0.078 | -14.3% | $0.542 | $0.555 | $0.452 | 1,233,900 | |
| $0.547 | +0.002 | +0.3% | $0.549 | $0.578 | $0.546 | 116,712 | |
| $0.546 | -0.024 | -4.3% | $0.555 | $0.572 | $0.525 | 283,788 | |
| $0.57 | -0.072 | -11.2% | $0.63 | $0.65 | $0.557 | 531,088 | |
| $0.642 | -0.005 | -0.8% | $0.669 | $0.67 | $0.612 | 719,132 | |
| $0.647 | -0.019 | -2.8% | $0.66 | $0.70 | $0.607 | 578,522 | |
| $0.666 | +0.012 | +1.8% | $0.642 | $0.693 | $0.642 | 69,123 | |
| $0.654 | -0.061 | -8.5% | $0.72 | $0.75 | $0.63 | 329,026 | |
| $0.715 | -0.049 | -6.5% | $0.79 | $0.83 | $0.711 | 280,833 | |
| $0.765 | -0.301 | -28.2% | $1.06 | $1.06 | $0.746 | 1,023,461 | |
| $1.065 | -0.185 | -14.8% | $1.24 | $1.25 | $1.06 | 505,922 | |
| $1.25 | +0.13 | +11.6% | $1.12 | $1.30 | $1.11 | 652,977 | |
| $1.12 | +0.03 | +2.8% | $1.09 | $1.13 | $1.09 | 111,449 | |
| $1.09 | -0.03 | -2.7% | $1.135 | $1.15 | $1.08 | 139,908 | |
| $1.12 | -0.03 | -2.6% | $1.10 | $1.14 | $1.085 | 187,531 | |
| $1.15 | +0.05 | +4.5% | $1.12 | $1.17 | $1.05 | 886,900 | |
| $1.10 | +0.02 | +1.9% | $1.10 | $1.205 | $1.08 | 1,139,715 | |
| $1.08 | 0.00 | 0.0% | $1.08 | $1.10 | $1.06 | 83,465 | |
| $1.08 | +0.01 | +0.9% | $1.06 | $1.09 | $1.06 | 141,116 | |
| $1.07 | 0.00 | 0.0% | $1.08 | $1.10 | $1.05 | 87,378 | |
| $1.07 | -0.04 | -3.6% | $1.09 | $1.10 | $1.05 | 98,904 | |
| $1.11 | +0.02 | +1.8% | $1.11 | $1.15 | $1.08 | 177,026 | |
| $1.09 | -0.06 | -5.2% | $1.15 | $1.16 | $1.09 | 189,751 | |
| $1.15 | +0.05 | +4.5% | $1.11 | $1.17 | $1.09 | 436,378 | |
| $1.10 | +0.02 | +1.9% | $1.09 | $1.10 | $1.061 | 85,325 | |
| $1.08 | +0.07 | +6.9% | $1.02 | $1.10 | $0.99 | 356,806 | |
| $1.01 | +0.064 | +6.8% | $0.96 | $1.044 | $0.96 | 300,544 | |
| $0.946 | +0.005 | +0.6% | $0.955 | $1.028 | $0.906 | 413,727 | |
| $0.94 | 0.00 | -0.1% | $0.983 | $0.984 | $0.94 | 271,369 | |
| $0.941 | -0.199 | -17.5% | $1.10 | $1.10 | $0.93 | 1,542,763 | |
| $1.14 | +0.03 | +2.7% | $1.11 | $1.16 | $1.11 | 210,402 | |
| $1.11 | -0.01 | -0.9% | $1.14 | $1.17 | $1.11 | 104,126 | |
| $1.12 | +0.02 | +1.8% | $1.18 | $1.25 | $1.11 | 280,419 | |
| $1.10 | -0.02 | -1.8% | $1.12 | $1.12 | $1.09 | 85,893 | |
| $1.12 | 0.00 | 0.0% | $1.14 | $1.15 | $1.10 | 118,463 | |
| $1.12 | -0.04 | -3.4% | $1.14 | $1.19 | $1.12 | 85,838 | |
| $1.16 | 0.00 | 0.0% | $1.18 | $1.19 | $1.141 | 60,805 | |
| $1.16 | 0.00 | 0.0% | $1.18 | $1.197 | $1.12 | 99,686 | |
| $1.16 | -0.03 | -2.5% | $1.19 | $1.22 | $1.14 | 70,498 | |
| $1.19 | -0.05 | -4.0% | $1.23 | $1.23 | $1.15 | 194,672 | |
| $1.24 | +0.03 | +2.5% | $1.21 | $1.272 | $1.20 | 70,138 | |
| $1.21 | -0.05 | -4.0% | $1.26 | $1.285 | $1.18 | 158,127 | |
| $1.26 | +0.01 | +0.8% | $1.25 | $1.285 | $1.22 | 119,057 | |
| $1.25 | +0.02 | +1.6% | $1.23 | $1.27 | $1.215 | 79,291 | |
| $1.23 | +0.01 | +0.8% | $1.24 | $1.30 | $1.22 | 171,011 | |
| $1.22 | +0.01 | +0.8% | $1.30 | $1.31 | $1.20 | 326,550 | |
| $1.21 | +0.06 | +5.2% | $1.18 | $1.23 | $1.13 | 293,297 | |
| $1.15 | +0.05 | +4.5% | $1.13 | $1.16 | $1.08 | 329,353 |
Splits
1 split · NASDAQ:CODX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation |
- Ticker
- BOATS:CODX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Co-Diagnostics Announces Reverse Stock Split
Latest earnings call · Nov 12, 2026
Co-Diagnostics (NASDAQ:CODX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Sep 16, 2026
Corporate Update (September 2026)
Corporate update · 14 slides
Latest news
Co-Diagnostics Announces Reverse Stock Split
Nov 19, 2026
Closed $0.13 (-21.3%) on Nov 20, 2026
Co-Diagnostics Receives Logix Smart® ZDC Test Order from Peru Distributor as Dengue Cases Rise and Exhibits at MEDICA 2026 in Düsseldorf
Nov 17, 2026
Closed $0.196 (-12.9%) on Nov 17, 2026
Co-Diagnostics Reports Third Quarter 2026 Financial Results
Nov 10, 2026
Closed $0.289 (-9.5%) on Nov 10, 2026
Co-Diagnostics Announces Updated Third Quarter 2026 Earnings Release Date and Webcast
Nov 5, 2026
Closed $0.257 (-3.9%) on Nov 6, 2026
Co-Diagnostics to Participate in Three Global Tuberculosis Events in November as CoSara Advances Toward Anticipated India Launch
Nov 5, 2026
Closed $0.267 (-26.1%) on Nov 5, 2026
Co-Diagnostics Announces Third Quarter 2026 Earnings Release Date and Webcast
Oct 29, 2026
Closed $0.395 (-10.5%) on Oct 29, 2026
Co-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® Test
Oct 29, 2026
Closed $0.395 (-10.5%) on Oct 29, 2026
Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
Oct 27, 2026
Closed $0.469 (-14.3%) on Oct 27, 2026
Co-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing Forum
Oct 20, 2026
Closed $0.647 (-2.8%) on Oct 20, 2026
Co-Diagnostics Highlights PCR Platform Capabilities for Potential Plague Detection
Oct 15, 2026
Closed $0.715 (-6.5%) on Oct 15, 2026
Co-Diagnostics, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 57 in the last 12 months · 223 in all · newest Nov 19, 2026 · oldest 2019
- Calls
- 26 calls with a replay · 26 with a transcript · latest Nov 12, 2026
- Decks
- 2 decks · latest Sep 16, 2026
Where Co-Diagnostics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CODX · Home listing | NASDAQ | United States | USD |
| BOATS:CODX · This page | BOATS | United States | USD |
| LSE:0A50 | LSE | United Kingdom | USD |
| LS Exchange:A41UNJ | LS Exchange | Germany | EUR |
| gettex:C970 | gettex | Germany | EUR |
| Lang & Schwarz:A41UNJ | Lang & Schwarz | Germany | EUR |
| Munich:C970 | Munich | Germany | EUR |
Valuation
EV/sales 2.6× against a median of 1.6×: 5th lowest of 8 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.21M USD
- P/E
- Loss
- EV/sales
- 2.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.1×
- Gross margin
- 20.3%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 2.16
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics, Inc. · NASDAQ:CODX | US$1.36M | US$2.21M | n/a | 2.6× | n/a | 0.1× | n/a | 0.2× | 2.16 |
| Telo Genomics Corp. · TSXV:TELO | US$2.80M | US$2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 |
| Advanced Biomed Inc. · NASDAQ:ADVB | US$2.73M | US$3.12M | 0.5× | 12.2× | n/a | 0.2× | n/a | 0.1× | 0.35 |
| Innovotech Inc. · TSXV:IOT | US$2.66M | US$2.51M | n/a | 1.0× | n/a | 1.5× | −21.1% | 0.1× | 0.39 |
| Qlife Holding AB · OMXSTO:QLIFE | US$2.49M | US$2.88M | n/a | 34.1× | n/a | 9.6× | n/a | 3.1× | n/a |
| Physiomics PLC · LSE:PYC | US$2.46M | US$1.91M | n/a | 1.6× | n/a | 3.6× | −74.1% | 0.0× | n/a |
| 20/20 BioLabs, Inc. · NASDAQ:AIDX | US$2.10M | −US$1.01M | n/a | −0.5× | n/a | 3.4× | −317.8% | 0.9× | 1.41 |
| Bluejay Diagnostics, Inc. · NASDAQ:BJDX | US$1.90M | −US$5.43M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.71 |
| Accustem Sciences Inc · OTC:ACUT | US$1.90M | US$1.88M | n/a | n/a | n/a | n/a | n/a | n/a | 0.19 |
| InVitro International · OTC:IVRO | US$1.87M | US$644,260 | 29.6× | 0.8× | 14.0× | 1.1× | 8.2% | 0.0× | 0.17 |
| Prostatype Genomics AB · OMXSTO:PROGEN | US$1.36M | US$1.32M | n/a | 13.3× | n/a | 2.1× | n/a | 0.0× | n/a |
| Median of the others | US$2.28M | US$1.90M | 15.1× | 1.6× | 14.0× | 1.8× | −47.6% | 0.0× | 0.35 |
Forecasts
1 buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 4.00 USD · Analysts' mean
- EPS, year to Dec 2026
- -3.10 · 1 analyst
- Revenue, year to Dec 2026
- 654K · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Dwight H. Egan | Chief Executive Officer |
| Richard Abbott | President |
| Andrew Benson | Head of Investor Relations |
| Mayuranki Almaula | Sr. VP Overseas Operations and Strategic Alliances |
| Noriko Kusukawa | Vice President |
| Christopher Thurston | Chief Technology Officer |
| David Nielsen | Chief Operations Officer |
| Seth Egan | Chief Commercialization Officer |
| Wes Lindsey | Chief Scientific Officer |
Board
| Director | Role |
|---|---|
| Carl Wittwer | Chair |
Events
Calls
| Call | When | Status |
|---|---|---|
| Co-Diagnostics (NASDAQ:CODX) Q3 2026 Earnings Call | Thu, Nov 12, 2026 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q1 2026 Earnings Call | Thu, May 14, 2026 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q4 2025 Earnings Call | Tue, Mar 31, 2026 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q3 2025 Earnings Call | Thu, Nov 13, 2025 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q2 2025 Earnings Call | Thu, Aug 14, 2025 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q1 2025 Earnings Call | Fri, May 09, 2025 · 2:30 AM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q4 2024 Earnings Call | Thu, Mar 27, 2025 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 4:30 PM ET | Replay |
| Co-Diagnostics (NASDAQ:CODX) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
All 26 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 10, 2026 · Before open | −9.5% |
| Q2 2026 | Aug 13, 2026 · After close | −6.0% |
| Q1 2026 | May 14, 2026 · After close | −21.2% |
| Q4 2025 | Mar 19, 2026 | +12.1% |
| Q3 2025 | Nov 13, 2025 · After close | −10.9% |
| Q2 2025 | Aug 14, 2025 · After close | +10.8% |
| Q1 2025 | May 8, 2025 · After close | −4.3% |
| Q4 2024 | Mar 12, 2025 · Before open | +0.1% |
| Q3 2024 | Nov 7, 2024 · After close | −3.4% |
| Q2 2024 | Aug 8, 2024 · After close | +9.8% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · After close | −9.8% |
| Q4 2023 | Mar 14, 2024 · After close | −10.1% |
| Q3 2023 | Nov 9, 2023 · After close | −10.2% |
| Q2 2023 | Aug 10, 2023 · After close | −4.1% |
| Q1 2023 | May 11, 2023 · After close | +7.3% |
| Q4 2022 | Mar 16, 2023 · After close | −16.2% |
| Q3 2022 | Nov 10, 2022 · After close | +5.5% |
| Q2 2022 | Aug 11, 2022 · After close | −30.6% |
| Q1 2022 | May 12, 2022 · After close | +14.9% |
| Q4 2021 | Mar 24, 2022 · After close | −11.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (September 2026) | Corporate update | 14 slides | Sep 16, 2026 |
| Investor Presentation (2026) | Investor deck | 16 slides | 2026 |
Financings
| Raise | Date |
|---|---|
| Registered direct offering of shares of common stock (or pre-funded warrants in-lieu thereof) Closed: US$7M raised · US$0.55 a share · Maxim Group LLC Dealers: Maxim Group LLC (lead) Use of proceeds: Working capital and general corporate purposes | Oct 29, 2025 |
| Registered direct offering of common stock Closed: US$3.8M raised · US$0.4 a share · Maxim Group LLC Dealers: Maxim Group LLC (lead) Use of proceeds: Working capital and general corporate purposes | Sep 18, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$6.00 a share on Jul 12, 2017.
- Price
- US$6.00 a share
- Shares offered
- 1,178,532 shares of common stock
- Offering size
- US$7.1 million
- Listing
- CODX on the Nasdaq Capital Market
- Underwriters
- WallachBeth Capital, LLC, Network 1 Financial Securities, Inc., ViewTrade Securities, Inc. · In the order on the cover
- Shares delivered
- On or about Jul 17, 2017
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jan 12, 2017 |
| Filed publicly | Apr 28, 2017 |
| Amended 4 times | Newest Jul 10, 2017 |
| Shares registered with an exchange | Jul 11, 2017 |
| Declared effective by the SEC | Jul 11, 2017 |
| Final prospectus, with the price | Jul 13, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jul 14, 2017 |
| 424B4 · Prospectus | Jul 13, 2017 |
| CORRESP · Letter to the SEC | Jul 12, 2017 |
| EFFECT · Notice that a registration is effective | Jul 11, 2017 |
| CORRESP · Letter to the SEC | Jul 11, 2017 |
| CERTNAS · Nasdaq's certificate of listing | Jul 11, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Jul 11, 2017 |
| S-1/A · Registration statement, amended | Jul 10, 2017 |
| CORRESP · Letter to the SEC | Jun 28, 2017 |
| S-1/A · Registration statement, amended | Jun 23, 2017 |
All 23 filings
| Filing | Filed |
|---|---|
| CORRESP · Letter to the SEC | Jun 9, 2017 |
| FWP · Free writing prospectus | Jun 9, 2017 |
| S-1/A · Registration statement, amended | Jun 9, 2017 |
| UPLOAD · Letter from the SEC | Jun 5, 2017 |
| CORRESP · Letter to the SEC | May 24, 2017 |
| S-1/A · Registration statement, amended | May 24, 2017 |
| UPLOAD · Letter from the SEC | May 18, 2017 |
| S-1 · Registration statement | Apr 28, 2017 |
| UPLOAD · Letter from the SEC | Apr 21, 2017 |
| DRS/A · Draft registration statement, amended | Mar 31, 2017 |
| DRSLTR · Letter to the SEC with a draft | Mar 30, 2017 |
| UPLOAD · Letter from the SEC | Feb 9, 2017 |
| DRS · Draft registration statement | Jan 12, 2017 |
Open IPO · From the cover of the final prospectus (424B4) filed Jul 13, 2017
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 622.5K | 3.92M | 6.81M | 34.2M | 97.9M | 74.6M | 215.0K | 39.9K | 7.66K | 0 |
| Cost of revenue | 222.4K | 999.1K | 4.18M | 5.48M | 11.6M | 16.6M | 112.4K | 9.39K | 302 | 37.5K |
| Gross profit | 400.1K | 2.92M | 2.63M | 28.7M | 86.3M | 58.0M | 102.5K | 30.5K | 7.36K | -37.5K |
| Research and development | 19.1M | 21.0M | 23.0M | 17.4M | 15.0M | 3.19M | 1.37M | 1.36M | 1.00M | 731.5K |
| Selling, general and administrative | 9.06M | 16.2M | 14.3M | 14.3M | 11.6M | 8.28M | 3.50M | 3.57M | 3.10M | 796.9K |
| Operating income | -50.2M | -40.1M | -42.7M | -27.0M | 46.1M | 41.7M | -5.89M | -6.12M | -4.56M | -1.69M |
| Depreciation and amortization | 1.11M | 1.38M | 1.23M | 1.28M | 335.4K | 138.6K | 65.9K | 50.8K | 45.8K | 37.5K |
| EBITDA | -49.1M | -38.7M | -41.5M | -25.7M | 46.4M | 41.8M | -5.83M | -6.07M | -4.52M | -1.65M |
| Interest expense | 14.9M | 473.5K | 175 | 106.4K | 71.0K | 310.2K | 240.7K | |||
| Income before tax | -48.5M | -37.6M | -38.1M | -18.8M | 45.6M | 42.6M | -6.20M | -6.27M | -6.96M | -1.93M |
| Income tax | -1.62M | 57.4K | -2.78M | -4.61M | 8.98M | 90.5K | -126.4K | -19.0K | 293.8K | 0 |
| Net income | -46.9M | -37.6M | -35.3M | -14.2M | 36.7M | 42.5M | -6.20M | -6.27M | -6.96M | -1.93M |
| Earnings per share, basic | -35.25 | -37.22 | -1.20 | -0.45 | 1.27 | 1.59 | -0.37 | -0.50 | -0.63 | -0.20 |
| Earnings per share, diluted | -35.25 | -37.22 | -1.20 | -0.45 | 1.23 | 1.52 | -0.37 | -0.50 | -0.63 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.9M | 2.94M | 14.9M | 23.0M | 88.6M | 43.0M | 893.1K | 950.2K | 3.53M | 998.7K |
| Short-term investments | 0 | 26.8M | 43.6M | 58.3M | 1.26M | 4.34M | 0 | |||
| Receivables | 190.4K | 132.6K | 303.9K | 3.45M | 20.8M | 12.1M | 131.4K | 13.4K | 3.18K | |
| Inventory | 992.4K | 1.07M | 1.66M | 5.31M | 2.00M | 8.00M | 197.2K | 18.2K | 9.07K | |
| Current assets | 13.7M | 32.3M | 62.1M | 92.7M | 115.1M | 67.8M | 1.58M | 1.05M | 4.45M | 1.21M |
| Property, plant and equipment | 2.27M | 2.76M | 3.04M | 2.54M | 1.93M | 949.6K | 196.8K | 156.1K | 165.6K | 87.4K |
| Goodwill | 0 | 14.7M | 0 | 0 | ||||||
| Total assets | 24.7M | 63.6M | 95.3M | 123.1M | 160.0M | 71.2M | 2.22M | 1.55M | 4.66M | 1.30M |
| Accounts payable | 1.88M | 3.29M | 1.48M | 952.3K | 607.5K | 598.3K | 5.96K | 149.0K | 40.8K | 29.9K |
| Current liabilities | 3.54M | 7.32M | 5.75M | 3.87M | 12.6M | 4.06M | 328.1K | 2.35M | 628.3K | 3.85M |
| Long-term debt | 1.91M | 277.7K | 445.0K | |||||||
| Total debt | 1.24M | 2.15M | 2.99M | 347.9K | 3.82M | 2.56M | ||||
| Total liabilities | 4.11M | 9.69M | 9.31M | 8.57M | 25.6M | 4.54M | 478.1K | 2.61M | 811.8K | 4.29M |
| Shareholders' equity | 20.6M | 53.9M | 85.6M | 114.5M | 134.5M | 66.7M | 1.74M | -1.06M | 3.85M | -2.99M |
| Shares outstanding | 2.10M | 1.10M | 31.3M | 30.9M | 33.8M | 28.6M | 17.3M | 12.9M | 12.3M | 9.88M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -29.1M | -29.2M | -22.1M | 6.57M | 41.1M | 28.2M | -5.53M | -4.08M | -3.21M | -1.31M |
| Capital spending | -700.0K | -748.4K | -1.37M | -1.43M | -669.5K | -774.4K | -113.2K | -41.3K | -129.3K | -12.2K |
| Free cash flow | -29.8M | -29.9M | -23.4M | 5.14M | 40.4M | 27.4M | -5.64M | -4.12M | -3.34M | -1.32M |
| Cash from investing | 26.3M | 17.1M | 15.4M | -58.2M | 4.10M | -5.82M | -435.2K | -380.3K | -189.3K | -12.2K |
| Cash from financing | 11.8M | 103.9K | -1.36M | -14.0M | 450.4K | 19.7M | 5.90M | 1.88M | 5.94M | 2.29M |
| Dividends paid | 0 | |||||||||
| Share buybacks | 0 | -1.36M | -14.2M | 450.4K | 19.7M | 5.90M | 30.0K | 7.07M | 7.07M | |
| Change in cash | 8.95M | -12.0M | -8.06M | -65.6M | 45.6M | 42.1M | -57.1K | -2.58M | 2.54M | 964.9K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 20, 2026 | Material contract | SEC |
| 8-K · Current report | Nov 19, 2026 | Current report | SEC |
| 8-K · Current report | Nov 13, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2026 | Results | SEC |
| S-3 · Registration statement | Nov 4, 2026 | Offer document | SEC |
| DEF 14A · Proxy statement | Oct 26, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 19, 2026 | Meeting notice | SEC |
| 8-K · Current report | Oct 15, 2026 | Meeting outcome | SEC |
| 8-K/A · Current report, amended | Oct 15, 2026 | Material contract | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Oct 13, 2026 | Material contract | SEC |
| 8-K · Current report | Oct 2, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Sep 25, 2026 | Meeting outcome | SEC |
| PRE 14A · Preliminary proxy statement | Sep 21, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 16, 2026 | Current report | SEC |
| 8-K · Current report | Sep 16, 2026 | Current report | SEC |
| 8-K · Current report | Sep 15, 2026 | Current report | SEC |
| 3 · Initial statement of ownership | Sep 14, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 4, 2026 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Sep 4, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 4, 2026 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Sep 2, 2026 | Other filings | SEC |
| S-3 · Registration statement | Aug 24, 2026 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 10, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jul 31, 2026 | Material contract | SEC |
| 8-K · Current report | Jul 27, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Jul 27, 2026 | Offer document | SEC |
| DEF 14A · Proxy statement | Jul 21, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jul 9, 2026 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 3, 2026 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Jun 1, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 28, 2026 | Other filings | SEC |
| S-3 · Registration statement | May 28, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | May 28, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2026 | Insider trade | SEC |
| DRS · Draft registration statement | May 22, 2026 | Offer document | SEC |
| 8-K · Current report | May 21, 2026 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | May 18, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 14, 2026 | Results | SEC |
| CORRESP · Letter to the SEC | May 13, 2026 | Other filings | SEC |
| S-3 · Registration statement | May 12, 2026 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 14, 2026 | Other filings | SEC |
| DRS · Draft registration statement | Apr 10, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 31, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 31, 2026 | Results | SEC |
| 8-K · Current report | Mar 10, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 11, 2026 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jan 21, 2026 | Offer document | SEC |
| 8-K · Current report | Jan 13, 2026 | Current report | SEC |
| 8-K · Current report | Dec 30, 2025 | Current report | SEC |
| 424B5 · Prospectus | Dec 19, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 5, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 24, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 13, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2025 | Big-stake notice | SEC |
| DEF 14A · Proxy statement | Nov 10, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 31, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 30, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 29, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Oct 28, 2025 | Offer document | SEC |
| 8-K · Current report | Oct 20, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Oct 20, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 30, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Sep 19, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Sep 18, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Sep 18, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Sep 18, 2025 | Offer document | SEC |
| 424B5 · Prospectus | Sep 16, 2025 | Offer document | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 15, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2025 | Results | SEC |
| 8-K · Current report | Jul 11, 2025 | Current report | SEC |
| 8-K · Current report | May 29, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| 8-K · Current report | Apr 28, 2025 | Material contract | SEC |
| DEF 14A · Proxy statement | Apr 14, 2025 | Meeting notice | SEC |
| 10-K · Annual report | Mar 27, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 27, 2025 | Results | SEC |
| 8-K · Current report | Feb 21, 2025 | Current report | SEC |
| 8-K · Current report | Jan 10, 2025 | Current report | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2024 | Insider trade | SEC |
| 8-K/A · Current report, amended | Nov 8, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| 424B5 · Prospectus | Oct 18, 2024 | Offer document | SEC |
| 8-K · Current report | Aug 30, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| DEF 14A · Proxy statement | Jul 16, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jun 14, 2024 | Current report | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 29, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 20, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 15, 2024 | Management or board change | SEC |
| 10-K · Annual report | Mar 14, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 14, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 8-K · Current report | Aug 31, 2023 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 10, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2023 | Results | SEC |
| DEF 14A · Proxy statement | Jul 20, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 24, 2023 | Insider trade | SEC |
| 8-K · Current report | May 16, 2023 | Management or board change | SEC |
| 4 · Change in ownership | May 15, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2023 | Results | SEC |
| EFFECT · Notice that a registration is effective | Apr 7, 2023 | Other filings | SEC |
| 8-K · Current report | Apr 5, 2023 | Current report | SEC |
| CORRESP · Letter to the SEC | Apr 4, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 22, 2023 | Other filings | SEC |
| 4 · Change in ownership | Mar 21, 2023 | Insider trade | SEC |
| S-3 · Registration statement | Mar 16, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 16, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 16, 2023 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2023 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jan 23, 2023 | Offer document | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 19, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 9, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 9, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 9, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 9, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2022 | Insider trade | SEC |
This page holds 200 of 395 filings. Open Filings
Cap table
Built by 6ix from Co-Diagnostics, Inc.’s releases · as of Nov 6, 2026
- Common shares
- 10,512,190
- Fully diluted
- 10,512,190
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 10,512,190 | Nov 6, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 6, 2026 | 10,512,190 |
| Sep 30, 2026 | 7,288,601 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrew Benson | Head of Investor Relations · Since at least Jul 16, 2026 |
| Brent Satterfield | Former Chief Science Officer · Jul 11, 2017 – Feb 23, 2021 · Past |
| Brian Lee Brown | Chief Financial Officer · Since at least May 23, 2025 |
| Carl Wittwer | Chair · Since at least Nov 4, 2026 |
| Christopher Thurston | Chief Technology Officer · Since at least Feb 4, 2026 |
| Daniel Bohrer | EVP of Finance & Accounting · Since at least Sep 2, 2026 |
| David Nielsen | Chief Operations Officer · Since at least Nov 5, 2026 |
| Dwight H. Egan | Chief Executive Officer · Since at least Jul 11, 2017 |
| Edward L Murphy | Director · Since at least Apr 24, 2019 |
| Eugene Durenard | Director · Since at least Jul 11, 2022 |
All 20 people
| Person | Seat |
|---|---|
| Frank J Kiesner | Director · Jul 11, 2017 – Jul 11, 2017 · Past |
| James B Nelson | Director · Since at least Sep 3, 2019 |
| Mayuranki Almaula | Sr. VP Overseas Operations and Strategic Alliances · Since at least Nov 5, 2026 |
| Noriko Kusukawa | Vice President · Since at least Nov 4, 2026 |
| Richard Abbott | President · Since at least Mar 15, 2024 |
| Richard S Serbin | Director · Since at least Jul 11, 2017 |
| Seth Egan | Chief Commercialization Officer · Since at least Sep 23, 2026 |
| Ted Murphy | Director · Since at least Jan 8, 2022 |
| Wes Lindsey | Chief Scientific Officer · Since at least Jul 16, 2026 |
| Wes Lindsey | Chief Scientific Officer · Since Jul 16, 2026 · Appointed, no departure found |
Log in to ask 6ix AI your own questions about Co-Diagnostics, Inc.